Subsequently, we discovered that the mitochondria-targeted metabolic interfering agent, triphenyl-phosphonium-carboxy-proxyl (Mito-CP), can also effectively suppress MTC cells via similar mechanisms as induced by mortalin targeting [15,16]. This evidence concerns the gene HSPA9 and medullary thyroid gland carcinoma.